Virginie Durbecq
- Oncology top 1%
- Cancer Research top 1%
- Molecular Biology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Christos SotiriouDenis LarsimontFátima CardosoMarianne PaesmansMartine PiccartMax S. ManoEvandro de AzambujaM. Piccart-Gebhart
- Topics
- HER2/EGFR in Cancer Research (19 papers)Breast Cancer Treatment Studies (17 papers)Cancer Treatment and Pharmacology (10 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- BelgiumUnited KingdomItaly
In The Last Decade
Virginie Durbecq
64 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Oncology 1.8k
- Cancer Research 1.5k
- Molecular Biology 1.3k
- Pulmonary and Respiratory Medicine 454
- Pathology and Forensic Medicine 433
Countries citing papers authored by Virginie Durbecq
This map shows the geographic impact of Virginie Durbecq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginie Durbecq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginie Durbecq more than expected).
Fields of papers citing papers by Virginie Durbecq
This network shows the impact of papers produced by Virginie Durbecq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginie Durbecq. The network helps show where Virginie Durbecq may publish in the future.
Co-authorship network of co-authors of Virginie Durbecq
This figure shows the co-authorship network connecting the top 25 collaborators of Virginie Durbecq. A scholar is included among the top collaborators of Virginie Durbecq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginie Durbecq. Virginie Durbecq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 31 | |
| 2 | 227 | |
| 3 | 55 | |
| 4 | 2 | |
| 5 | 44 | |
| 6 | Topoisomerase-II as a predictive marker for response to anthracyclines | 1 |
| 7 | 32 | |
| 8 | 49 | |
| 9 | 59 | |
| 10 | 49 | |
| 11 | Four genes by RT-PCR predicts distant relapse for women given adjuvant tamoxifen | 2 |
| 12 | Better characterization of estrogen receptor (ER) positive luminal subtypes using genomic grade | 7 |
| 13 | Topoisomerase II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated with single-agent doxorubicin or single-agent docetaxel | 40 |
| 14 | Molecular classification of breast carcinomas by immunohistochemistry (IHC) using the tissue microarrays (TMA): new subtypes with clinical relevance? | 1 |
| 15 | 121 | |
| 16 | 42 | |
| 17 | p-53 gene mutations as a predictive marker in advanced breast cancer patients randomly treated either with doxorubicin or with docetaxel | 2 |
| 18 | 28 | |
| 19 | 17 | |
| 20 | 8 |
About Virginie Durbecq
Virginie Durbecq is a scholar working on Cancer Research, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 64 papers that have together received 3.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (19 papers), Breast Cancer Treatment Studies (17 papers) and Cancer Treatment and Pharmacology (10 papers). The work is most often cited by research in Cancer Research (1.5k citations), Oncology (1.8k citations) and Pathology and Forensic Medicine (433 citations). Virginie Durbecq has collaborated with scholars based in Belgium, United Kingdom and Italy. Frequent co-authors include Christos Sotiriou, Denis Larsimont, Fátima Cardoso, Marianne Paesmans, Martine Piccart, Max S. Mano, Evandro de Azambuja, M. Piccart-Gebhart, Gilberto de Castro and Angelo Di Leo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.